Participants 32 78 7
children with systemic ventricular dysfunction
Participants 174 218 3
heart failure therapy in adults and children
Participants 505 632 5
a population of children with systemic ventricular dysfunction and symptomatic heart failure treated with carvedilol or placebo
Participants 690 772 5
Pediatric Carvedilol Trial (PCT) participants (carvedilol n = 161; placebo n = 55)
Participants 1098 1130 3
children treated with carvedilol
Participants 1354 1370 3
carvedilol group
Participants 1418 1482 3
children with systemic ventricular dysfunction and heart failure
